NCT00066924

Brief Summary

The purpose of this study is to determine whether religiosity and spirituality are related to immune functioning, as measured by interleukin-6 blood plasma level, among terminally ill cancer patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2003

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 7, 2003

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 8, 2003

Completed
24 days until next milestone

Study Start

First participant enrolled

September 1, 2003

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2004

Completed
Last Updated

June 24, 2005

Status Verified

May 1, 2005

First QC Date

August 7, 2003

Last Update Submit

June 23, 2005

Conditions

CancerDepressionDying Process

Keywords

spiritualityreligiosityimmune functioningpsychoneuroimmunologycytokinescancerdeathdepression

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inpatient at Calvary Hospital
  • Diagnosis of terminal cancer
  • Score of 20 or above on Mini-Mental State Exam

You may not qualify if:

  • Presence of a psychiatric disorder that would preclude the production of meaningful data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Calvary Hospital

The Bronx, New York, United States

Location

Related Publications (1)

  • McClain CS, Rosenfeld B, Breitbart W. Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients. Lancet. 2003 May 10;361(9369):1603-7. doi: 10.1016/S0140-6736(03)13310-7.

    PMID: 12747880BACKGROUND

MeSH Terms

Conditions

NeoplasmsDepressionDeath

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Barry Rosenfeld, PhD

    Fordham University

    PRINCIPAL INVESTIGATOR

  • William Breitbart, MD

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
OTHER
Sponsor Type
NIH

Study Record Dates

First Submitted

August 7, 2003

First Posted

August 8, 2003

Study Start

September 1, 2003

Study Completion

June 1, 2004

Last Updated

June 24, 2005

Record last verified: 2005-05

Locations

US(1)